Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by culturedpiggy01on Apr 06, 2022 4:51pm
222 Views
Post# 34582095

$ASEP & its novel, patented tech for early sepsis detection

$ASEP & its novel, patented tech for early sepsis detection

Keeping a close eye on $ASEP.c , they currently have patented and novel tech under development for early and accurate detection of sepsis and treatments for antibiotic resistance https://ceo.ca/@newswire/asep-medical-holdings-inc-announces-an-exclusive-licensing

once they’re able to bring these to market, the opportunity here is huge. An early sepsis diagnosis and treatment could save up to $22B in the US alone annually + plus save the lives of so many. keeping $ASEP on my watchlist for sure

td, $ASEP.c @ $0.40 MC $22.45 M

<< Previous
Bullboard Posts
Next >>